Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05967559
Other study ID # DeRDEN
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2020
Est. completion date July 1, 2022

Study information

Verified date July 2023
Source Namik Kemal University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cancer is one of the major health problems facing Turkey and the world. One of the methods used to treat cancer is chemotherapy. During this treatment period, some side effects may develop in patients. These developing symptoms can be managed with effective nursing interventions, which in turn can increase the patient's quality of life. Managing these symptoms is among the responsibilities of the nurse. The nurses' ability to effectively manage the side effects of chemotherapy depends on gaining specific knowledge, attitudes, and skills during their vocational training and the development of problem-solving and critical thinking. The research was carried out to examine the effect of chemotherapy symptom management education based on the online flipped learning model on the achievement, critical thinking, and self-directed learning of nursing students.


Description:

Background: The online flipped learning method is an innovative learning approach that helps develop critical thinking and self-directed learning skills and increases students' interest in the course Aim: The research was carried out to examine the effect of chemotherapy symptom management education based on the online flipped learning model on the achievement, critical thinking, and self-directed learning of nursing students. Methods: This research is a randomized controlled trial. The sample consisted of 68 students divided into experiment and control groups. The training program based on traditional learning was applied to the control group, online flipped learning was applied to the experiment group, and each group received training on chemotherapy symptom management for one hour per week for six weeks. The researchers evaluated the results by applying the Chemotherapy Symptom Management Knowledge Test (CSMKT), the Marmara Critical Thinking Dispositions Scale (MCTDS), and the Self-Directed Learning Skills Scale (SDLSS) to the control and experiment groups before, right after the training, and one month after the training.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date July 1, 2022
Est. primary completion date July 29, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 35 Years
Eligibility Inclusion Criteria: - Second-year students who took the course basics of nursing, internal medicine nursing, physiology, pathology, and computer courses and were able to actively use the computer and voluntarily participated in the research were included. Exclusion Criteria: - Students in other classes - Those who did not volunteer to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Online Flipped Learning Group
The experimental group is the group that receives online flipped learning training.
Traditional learning Group
The control group is the group that received traditional learning training.

Locations

Country Name City State
Turkey Tekirdag Namik Kemal University Tekirdag

Sponsors (1)

Lead Sponsor Collaborator
Namik Kemal University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Chemotherapy Symptom Management Knowledge Test (CSMKT) The Chemotherapy Symptom Management Knowledge Test (CSMKT) was developed by the researchers to evaluate the impact of chemotherapy symptom management training based on the online flipped learning model. The measurement tool was presented to the expert opinion. Necessary corrections were made in accordance with the views of the experts and validity and reliability analyzes were carried. The test consists of 25 questions with a total of five options.The minimum score that can be attainable from the scale is 0, and the maximum score is 100. As the total score increases, the academic success of the student increases. 1 month
Secondary Marmara Critical Thinking Dispositions Scale (MCTDS) The MCTDS was developed by Özgenel and Çetin (2018). The scale includes 28 items and six subdimensions: reasoning (six items), reaching judgment (six items), searching for evidence (four items), searching for the truth (four items), open-mindedness (four items), and systematicity (four items). It is a five-point Likert-type scale (5 = Always, 1 = Never). There are no reverse-scored items in the scale. The minimum score that can be attainable from the scale is 28, and the maximum score is 140. The Cronbach's alpha internal consistency coefficient of the scale was determined as a = 0.91 As the total score increases, the student's critical thinking dispositions increases. 1 month
Secondary Self-Directed Learning Skills Scale (SDLSS) The SDLLS was developed by Askin Tekkol and Demirel (2018). The scale includes 21 items and four subdimensions: motivation (seven items), self-control (five items), self-monitoring (five items), and self-confidence (four items). It is a five-point Likert-type scale (1 = Always, 5 = Never). There are no reverse-scored items in the scale. While the minimum score of the scale is 21, the maximum score is 105. The overall reliability, the Cronbach's alpha internal consistency coefficient, was determined as a = 0.89. As the total score increases, the student's self-directed learning skills increases. 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT06376604 - Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies N/A
Completed NCT03753542 - Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy N/A
Not yet recruiting NCT05022628 - Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis Phase 4
Completed NCT04207359 - Effects of Creatine Supplementation in Breast Cancer Survivors N/A
Active, not recruiting NCT04489173 - TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer Phase 2
Completed NCT04173195 - Comfort Talk (CT) During Outpatient Chemotherapy N/A
Recruiting NCT06041477 - Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC Phase 3
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Recruiting NCT03275194 - HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy Phase 2
Recruiting NCT04808466 - Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Phase 2
Recruiting NCT06421610 - OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. Phase 1
Completed NCT05131490 - Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients N/A
Completed NCT04118322 - The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy N/A
Recruiting NCT06043999 - Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients N/A
Recruiting NCT05515796 - Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors Phase 2
Not yet recruiting NCT04845490 - Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Phase 2
Recruiting NCT05424692 - Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer N/A
Recruiting NCT05992337 - New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
Recruiting NCT04989985 - S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma Phase 2
Enrolling by invitation NCT04027478 - Can Fasting Decrease the Side Effects of Chemotherapy? N/A